1 |
Huang S, Zou Y, Tang H, Zhuang J, Ye Z, Wei T, Lin J, Zheng Q. Cordyceps militaris polysaccharides modulate gut microbiota and improve metabolic disorders in mice with diet-induced obesity. J Sci Food Agric 2022. [PMID: 36571152 DOI: 10.1002/jsfa.12409] [Reference Citation Analysis]
|
2 |
Huang L, Liu Z, Wu P, Yue X, Lian Z, He P, Liu Y, Zhou R, Zhao J. Puerariae lobatae Radix Alleviates Pre-Eclampsia by Remodeling Gut Microbiota and Protecting the Gut and Placental Barriers. Nutrients 2022;14. [PMID: 36501055 DOI: 10.3390/nu14235025] [Reference Citation Analysis]
|
3 |
Shao M, Lu Y, Xiang H, Wang J, Ji G, Wu T. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Front Pharmacol 2022;13:971561. [DOI: 10.3389/fphar.2022.971561] [Reference Citation Analysis]
|
4 |
Guo W, Luo L, Meng Y, Chen W, Yu L, Zhang C, Qiu Z, Cao P. Luteolin alleviates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiome. Front Nutr 2022;9:936237. [PMID: 35990349 DOI: 10.3389/fnut.2022.936237] [Reference Citation Analysis]
|
5 |
Tong L, Feng Q, Lu Q, Zhang J, Xiong Z. Combined 1H NMR fecal metabolomics and 16 S rRNA gene sequencing to reveal the protective effects of Gushudan on Kidney-yang deficiency syndrome rats via gut-kidney axis. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Huang H, Chen J, Chen Y, Xie J, Xue P, Ao T, Chang X, Hu X, Yu Q. Metabonomics combined with 16S rRNA sequencing to elucidate the hypoglycemic effect of dietary fiber from tea residues. Food Research International 2022;155:111122. [DOI: 10.1016/j.foodres.2022.111122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
7 |
Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou T, Huang F, Guo X, Zhang H, Huang R, Han Z, Xing Y, Liu Q, Tong G, Zhou H. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. Pharmacol Res 2021;172:105849. [PMID: 34450307 DOI: 10.1016/j.phrs.2021.105849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
8 |
Dai X, Feng J, Chen Y, Huang S, Shi X, Liu X, Sun Y. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chin Med 2021;16:68. [PMID: 34344394 DOI: 10.1186/s13020-021-00469-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|